Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ENPP1 | P22413 | 3/20 | 0.56 |
| ▸ | KDM1A | O60341 | 1/20 | 0.50 |
| ▸ | IRAK1 | P51617 | 1/20 | 0.49 |
| ▸ | IRAK4 | Q9NWZ3 | 1/20 | 0.49 |
| ▸ | EGFR | P00533 | 7/20 | 0.48 |
| ▸ | HTT | P42858 | 2/20 | 0.48 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.48 |
| ▸ | LMNA | P02545 | 1/20 | 0.48 |
| ▸ | HPGD | P15428 | 1/20 | 0.48 |
| ▸ | LCK | P06239 | 1/20 | 0.47 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.46 |
| ▸ | ATM | Q13315 | 1/20 | 0.46 |
| ▸ | KIT | P10721 | 1/20 | 0.46 |
| ▸ | ACHE | P22303 | 1/20 | 0.46 |
| ▸ | BACE1 | P56817 | 1/20 | 0.46 |
| ▸ | PDGFRB | P09619 | 1/20 | 0.44 |
| ▸ | PDGFRA | P16234 | 1/20 | 0.44 |
| ▸ | RAF1 | P04049 | 1/20 | 0.44 |
| ▸ | KDR | P35968 | 2/20 | 0.43 |
| ▸ | ERBB2 | P04626 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL295891 | 0.91 | ENPP1 (0.68) | ENPP1KDM1AIRAK1IRAK4EGFR | |
| SCHEMBL297514 | 0.91 | ENPP1 (0.68) | ENPP1KDM1AIRAK1IRAK4EGFR | |
| SCHEMBL29631520 | 0.91 | ENPP1 (0.68) | ENPP1KDM1AIRAK1IRAK4EGFR | |
| Hydrochloric Acid SCHEMBL28102763 | 0.90 | ENPP1 (0.67) | ENPP1KDM1AIRAK1IRAK4EGFR | |
| Hydrochloric Acid SCHEMBL28041015 | 0.90 | ENPP1 (0.67) | ENPP1KDM1AIRAK1IRAK4EGFR | |
| Hydrochloric Acid SCHEMBL156332 | 0.90 | ENPP1 (0.67) | ENPP1KDM1AIRAK1IRAK4EGFR | |
| SCHEMBL8857758 | 0.89 | ENPP1 (0.56) | ENPP1KDM1AIRAK1IRAK4EGFR | |
| SCHEMBL4224921 | 0.81 | EGFR (0.48) | ENPP1KDM1AIRAK1IRAK4EGFR | |
| SCHEMBL10290852 | 0.81 | EGFR (0.48) | ENPP1KDM1AIRAK1IRAK4EGFR | |
| SCHEMBL7205078 | 0.80 | ENPP1 (0.67) | ENPP1KDM1AIRAK1IRAK4EGFR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8609673-B2 | Vandetanib derivatives | CONCERT PHARMACEUTICALS, INC. (US) | 2013-12-17 | — | — | US | disclosed |
| US-20110117084-A1 | VANDETANIB DERIVATIVES | CONCERT PHARMACEUTICALS, INC. (US) | 2011-05-19 | — | — | US | disclosed |
| WO-2009094210-A1 | VANDETANIB DERIVATIVES | CONCERT PHARMACEUTICALS INC. (US) | 2009-07-30 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110117084-A1 | VANDETANIB DERIVATIVES | KDR, VHL, FLT4 | ENPP1 702/4885KDM1A 3287/4885IRAK1 1642/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.